8 Coupons
harvard medical school: "cgrp: a new era for migraine treatment." .
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . .
"we were quite surprised to find there were no significant differences," says study author
.